JNK regulation of hepatic manifestations of the metabolic syndrome.
about
Implication of hepatokines in metabolic disorders and cardiovascular diseasesStress kinases in the modulation of metabolism and energy balancec-Jun amino-terminal kinase-1 mediates glucose-responsive upregulation of the RNA editing enzyme ADAR2 in pancreatic beta-cellsc-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src.Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammationPeriostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling.INTRACELLULAR SIGNALING BY BILE ACIDS.Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylationStathmin mediates hepatocyte resistance to death from oxidative stress by down regulating JNK.Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway.Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells.Cytochrome P4502E1, oxidative stress, JNK, and autophagy in acute alcohol-induced fatty liver.Effects of ambient and preceding temperatures and metabolic genes on flight metabolism in the Glanville fritillary butterflyToll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in micePalmitic acid induces autophagy in hepatocytes via JNK2 activationDistinct functions of JNK and c-Jun in oxidant-induced hepatocyte death.Eicosanoids in metabolic syndrome.CHIP(-/-)-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications.Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals.Hepatic extracellular signal-regulated kinase 2 suppresses endoplasmic reticulum stress and protects from oxidative stress and endothelial dysfunctionInhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK.Host homeostatic responses to alcohol-induced cellular stress in animal models of alcoholic liver disease.Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes.The interaction of Wnt-11 and signalling cascades in prostate cancer.Pannexin1 contributes to pathophysiological ATP release in lipoapoptosis induced by saturated free fatty acids in liver cellsDiabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes.Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells.Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver.Molecular targets for antifibrotic therapy in liver disease: using magic bullets for crossfire rather than a one-sided shotgun attack.GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK.Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver.New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases.Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.Circulating LECT2 levels in newly diagnosed type 2 diabetes mellitus and their association with metabolic parameters: An observational study.Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK.Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis.Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.
P2860
Q26751147-5DB96EA3-9823-49C5-A0F9-0F32FFFB09DAQ26781375-34E8EC52-D788-4CE2-BAC8-A82DB21D2CB3Q28584787-9D9A838A-9663-4B5E-9A41-DA52881CF910Q30009024-1CB88676-6A98-48F8-96E8-75653F5A708CQ33908725-4AB7EBE7-3E3F-47FD-95FF-0A0256784FDEQ33944254-3FE5A17E-115F-4878-9A05-F94BE49A51CFQ34446469-FE264148-6548-4EAD-889F-85A9B50C24B2Q34448448-04699CA0-298E-432D-9905-0D43CC994DDAQ34666690-9D0771CB-CD84-4952-8420-A80CFBC64C36Q35303879-E37E3CFB-604C-45AA-A14A-82866478E031Q35903260-28DE706A-3AB9-4FE3-86B6-D16A6EF975C0Q35930758-EBC28925-63DD-4307-8AC5-31C6914B7CEEQ36203286-9BE2C87B-4968-4106-BC24-3F7D64CB7046Q36538012-4D76ECC4-76C5-4C0A-BC90-95E2A3AB32F4Q36592306-096F07C2-3894-4F14-82B6-D88B3D080E87Q36745177-B2378990-B686-41A8-86D2-3007564029FCQ36795583-B08C5676-584C-4D1A-9605-94DD25666E21Q36911098-C1FDF7BD-626D-48EA-AF05-837B3BD2D78BQ37089148-C2547521-F48F-4D1F-8013-C948C456D768Q37130138-7CCDA2E9-B709-4418-AC41-EF81F24F00FCQ37310401-A26FA206-4F82-48C2-B643-DA6C82FB5963Q37331725-33D22333-2034-4B06-9023-C9B0718A02D8Q38570690-F39B82F0-B398-4470-9459-1F81BEFB9BAEQ38594016-4E24B107-1B84-4516-B34D-0180FCF77865Q38924969-D34FA17F-D695-42B5-B700-90CB558EAD86Q39279987-CEC29B4E-DFB4-4A37-9F62-475ED4D1D90DQ41349411-48A11FBA-1A12-44CB-848C-578BC08CDAF9Q41522109-6529611F-EAC4-4C06-B562-A880CDBAEFB1Q41784712-CEB814EF-F840-478A-B82E-71CFDB1939A0Q43898859-C19A7D21-54C4-4628-AD6E-522A099DC4A4Q44870246-90B4CC56-EE58-4C88-B274-8D6CE1FB9742Q45351517-3EC32D85-A60A-4D57-81BC-A504A1593C7BQ45932834-9D62B03F-6357-4F95-A9DB-BF3CC0AC8A77Q51068461-9824BD02-5D1B-4FDB-A638-0AAB9EA08D2AQ52593843-E5AC20C4-CC66-4C1F-B4CF-A34CEFCBFCB7Q53624787-581FAD1F-7340-4B74-8835-8BB2878E4ED5Q54268449-AD98AD2E-DC43-4080-A453-123FD7F0CCC6Q54317961-941C6961-2DF7-48AB-8EA6-1B3108620EEB
P2860
JNK regulation of hepatic manifestations of the metabolic syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
JNK regulation of hepatic manifestations of the metabolic syndrome.
@ast
JNK regulation of hepatic manifestations of the metabolic syndrome.
@en
JNK regulation of hepatic manifestations of the metabolic syndrome.
@nl
type
label
JNK regulation of hepatic manifestations of the metabolic syndrome.
@ast
JNK regulation of hepatic manifestations of the metabolic syndrome.
@en
JNK regulation of hepatic manifestations of the metabolic syndrome.
@nl
prefLabel
JNK regulation of hepatic manifestations of the metabolic syndrome.
@ast
JNK regulation of hepatic manifestations of the metabolic syndrome.
@en
JNK regulation of hepatic manifestations of the metabolic syndrome.
@nl
P2860
P1476
JNK regulation of hepatic manifestations of the metabolic syndrome.
@en
P2093
Mark J Czaja
P2860
P304
P356
10.1016/J.TEM.2010.08.010
P577
2010-10-01T00:00:00Z